Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 9Recruiting 5Terminated 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colorectal Neoplasms 20Rectal Neoplasms 11Colonic Neoplasms 9Neoplasm Metastasis 7Carcinoma, Hepatocellular 6Pancreatic Neoplasms 5Stomach Neoplasms 4Recurrence 2Esophageal Neoplasms 2Adenocarcinoma Of Esophagus 2Peritoneal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Esophagogastric Cancer 1Esophageal Squamous Cell Carcinoma 1Clinical Stage I Gastric Cancer AJCC v8 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Borderline Resectable Pancreatic Adenocarcinoma 1Biliary Tract Neoplasms 1Adenocarcinoma 1

Interventions

Oxaliplatin 1Hyperthermic Intraperitoneal Chemotherapy 1Echocardiography 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Peritoneal Neoplasms × Oxaliplatin × Clear all
NCT03161041 2018-11-14

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP Study

Hospices Civils de Lyon

Phase 2 Withdrawn
Gynecologic

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡